Fortune Magazine Names Millennium Among 100 Best Companies to Work For

  Fortune Magazine Names Millennium Among 100 Best Companies to Work For

Business Wire

CAMBRIDGE, Mass. -- January 16, 2013

Millennium: The Takeda Oncology Company today announced it has been named
among the 100 Best Companies to Work For in the United States by FORTUNE. This
is the third consecutive year that Millennium, a wholly owned subsidiary of
Japan’s largest pharmaceutical company Takeda Pharmaceutical Company Limited,
has been included in the annual ranking. After breaking into the Top 100 list
at number 56 in 2011 Millennium has moved up to number 20.

“It’s such an honor to once again be recognized by FORTUNE as one of the Top
100 Companies to work for,” said Deborah Dunsire, M.D., President and Chief
Executive Officer, Millennium. “Being included in this very extraordinary list
for the third consecutive year speaks to the importance of our Company values
and our employees’ commitment to embracing these values. Respect, diversity
and putting the needs of patients first have always been at the core of
Millennium and will continue to be our guiding principles.”

“Thanks to companies like Millennium, Massachusetts is a world leader in life
sciences and biotechnology, leading the way forward in research and innovative
strategies,” said Massachusetts Governor Deval Patrick. “As a creative company
that has been successful and continues to grow, this recognition for
Millennium is well-deserved.”

Over the past year, Millennium has also been named a top employer by the
Boston Globe and Science magazine.

Methodology

To pick the 100 Best Companies to Work For, FORTUNE partners with the Great
Place to Work Institute to conduct the most extensive employee survey in
corporate America: 259 firms participated in this year’s survey. More than
277,000 employees at those companies responded to a survey created by the
institute, a global research and consulting firm operating in 45 countries
around the world. Two-thirds of a company’s score is based on the results of
the institute’s Trust Index survey, which is sent to a random sample of
employees from each company. The survey asks questions related to their
attitudes about management’s credibility, job satisfaction, and camaraderie.
The other third is based on responses to the institute’s Culture Audit, which
includes detailed questions about pay and benefit programs and a series of
open-ended questions about hiring practices, methods of internal
communication, training, recognition programs, and diversity efforts. After
evaluations are completed, if news about acompany comes to light that may
significantly damage employees’ faith in management, we may exclude it from
the list. Any company that is at least five years old and has more than 1,000
U.S. employees is eligible.

About Millennium

Millennium: The Takeda Oncology Company, a leading biopharmaceutical company
based in Cambridge, Mass., markets VELCADE, a first-in-class proteasome
inhibitor, and has a robust clinical development pipeline of product
candidates. Millennium Pharmaceuticals, Inc. was acquired by Takeda
Pharmaceutical Company Ltd. in May, 2008. The Company’s research, development
and commercialization activities are focused in oncology. Additional
information about Millennium is available through its website,
www.millennium.com.

Editors’ Note: This press release is also available under the Media section of
the Company’s website at: www.millennium.com/InTheNews.aspx.

Contact:

Millennium: The Takeda Oncology Company
Manisha Pai, 617-551-7877
Manisha.Pai@mpi.com
or
David Albaugh, 617-444-4457
David.albaugh@mpi.com
 
Press spacebar to pause and continue. Press esc to stop.